Saturday, July 11, 2026

Drug profile · INN

sodium iodide i-123

sodium iodide i-123 (SODIUM IODIDE I 123) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — sodium iodide i-123
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

sodium iodide i-123 (SODIUM IODIDE I 123) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sodium iodide i-123
Brand SODIUM IODIDE I 123
Route ORAL
Formulation CAPSULE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. sodium iodide Approved · United Therapeutics Europe · Transient Hypothyroxinemia

Frequently asked questions

What is sodium iodide i-123?

sodium iodide i-123 (SODIUM IODIDE I 123) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sodium iodide i-123?

SODIUM IODIDE I 123 is a marketed brand name for sodium iodide i-123. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium iodide i-123?

sodium iodide i-123 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.